Emerging biotechnology company Biocytogen raised 142 million dollars (USD) in support of Project Integrum
BEIJING and BOSTON, Sept. 24, 2020 /PRNewswire/ -- In August, Beijing Biocytogen Biotechnology Co., Ltd. ("Biocytogen") announced acquisition of Eucure Biopharma, which established Biocytogen as a clinical stage…
Read more
Strategic collaboration agreement reached between Biocytogen and Berkeley Lights for second Beacon Optofluidic system
September 14, 2020, Beijing | Beijing Biocytogen Co., Ltd. ("Biocytogen") reached a collaboration with Berkeley Lights Inc. ("Berkeley Lights") on the introduction of the second…
Read more
PEGS Boston Virtual Summit
Presentation Title: Accelerating Therapeutic Antibody Discovery with Three Distinct Humanized Mouse Models Time: 9:45 AM - 10:10 AM EDT on Monday, August 31 Programs: Antibody…
Read more
RenMab™ and RenLite™ Models Featured in GEN Magazine
In the August issue of Genetic Engineering & Biotechnology News, Biocytogen's RenMab (fully human antibody mouse) and RenLite (common light chain) models are introduced in the…
Read more
RenMab™ Mouse Platform Drives SARS CoV-2 Neutralizing Antibody Cocktail Therapy Towards Clinical Trials in Biocytogen and Eucure Biopharma Partnership
[MA, USA and Beijing, China - August] The COVID-19 pandemic has been an inescapable, lethal, and overwhelming aspect of daily human life, threatening health and…
Read more
Online: Tumor Models Boston Summit 2020
In Vivo Efficacy & Toxicity Evaluation Using Various Humanized Mouse Models to Increase Clinical Translation Time: Saturday, July 15 2020. 9:30 AM EST. Speaker: Qingcong Lin,…
Read more
AACR Virtual Annual Meeting II (Poster Session)
The AACR Foundation is the philanthropic arm of the American Association for Cancer Research (AACR). The Foundation supports the groundbreaking work of the AACR and…
Read more
Biocytogen is Featured in GEN’s Immunotherapy and Cancer Supplement Issue
Developing animal models for immunotherapy is often difficult due to the complexity of the immune system and tumor biology. Showcased in April’s GEN Magazine, Biocytogen…
Read more
Biocytogen CEO’s Response During COVID-19 Pandemic
Dear Valued Customer, The COVID-19 global outbreak has undoubtedly brought upon difficult times for individuals, families, and businesses around the world. Many of us have…
Read more
Biocytogen Announces Dr. Zhaoxue (Luke) Yu as Global Head of Preclinical Pharmacology
On March 31st, Biocytogen announced Dr. Zhaoxue (Luke) Yu as our Global Head of Preclinical Pharmacology. As our global preclinical pharmacology team leader, Dr. Yu…
Read more